Dec 17, 2018 07:03AM
Dec 17, 2018 02:00AM
Nov 27, 2018 11:32AM
Nov 27, 2018 06:30AM
Nov 13, 2018 07:04AM
Nov 13, 2018 02:00AM
Nov 1, 2018 04:00AM 3rd Quarter Results
Oct 25, 2018 03:00AM
Oct 18, 2018 05:45PM
Oct 18, 2018 01:44PM
Sep 20, 2018 07:02AM
Aug 23, 2018 05:44PM
Aug 23, 2018 03:15PM
May 10, 2018 04:05PM Caladrius Biosciences Reports 2018 First Quarter Financial Results
May 10, 2018 04:05PM
Apr 25, 2018 09:13AM
Apr 24, 2018 05:59PM
Apr 19, 2018 02:20PM
Apr 16, 2018 07:50AM
Mar 6, 2018 09:28AM
Mar 6, 2018 08:02AM Caladrius Biosciences (CLBS) Acquires License to Late Stage CD34+ Cell Therapy Program for Treatment of Refractory Angina
Mar 6, 2018 08:00AM
Mar 6, 2018 08:00AM
Feb 20, 2018 08:49AM
Jan 8, 2018 09:33AM
Nov 20, 2017 09:31AM
Nov 16, 2017 03:53PM
Oct 31, 2017 09:06AM Xenetic Biosciences (XBIO) Appoints Jeffrey Eisenberg as CEO
Oct 31, 2017 09:05AM
Jun 22, 2017 06:00AM
Jun 22, 2017 01:00AM
Jun 21, 2017 12:40PM
Jun 21, 2017 05:42AM
Jun 20, 2017 06:48PM
Jun 9, 2017 07:41AM Shire plc (SHPG): Cutting PT After Generic Arrives Earlier Than Expected - Jefferies
Jun 8, 2017 03:42PM
May 18, 2017 07:07AM
May 18, 2017 07:00AM
May 16, 2017 07:00AM
May 2, 2017 07:00AM
Mar 22, 2017 07:08AM
Mar 22, 2017 07:00AM Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura
Mar 6, 2017 01:57PM
Mar 6, 2017 01:55PM
Feb 16, 2017 09:29AM
Feb 16, 2017 07:52AM
Feb 15, 2017 11:46AM
Feb 7, 2017 03:47PM
Feb 7, 2017 03:42PM Shire Responds to U.S. Federal Trade Commission Civil Action
Feb 7, 2017 12:32PM

322,256 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All